[Acute therapy of ischemic cerebral infarct].
The ischaemic cerebral attack is a disease prevailingly of older age. Its prognosis is distinguished by a mortality rate as high as ever. From 1975 to 1985, 520 patients with ischaemic cerebral attack have been treated in hospital, with specific acute therapy changing from the so-called vasodilator therapy via osmotherapy into haemodilution therapy with lowmolecular dextrane. Since during vasodilator therapy any early mobilisation nor continuous physiotherapy were carried out and the patients prevailingly died of bronchopneumonia, the significantly lower mortality rate under osmotherapy and haemodilution therapy cannot be attributed to the specific drug therapy. In all probability it is a result of the improvement of care and of the active early mobilisation of the patients.
Schulz
J
J
Klinik für Innere Medizin und Geriatrie des Geriatrischen Zentrums Klinikum Berlin-Buch.
Jehle
A
A
Jehle
T
T
D000208:Acute Disease; D000368:Aged; D002544:Cerebral Infarction / Q000401:mortality / Q000628:therapy*; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D006438:Hemodilution / Q000379:methods; D006801:Humans; D006982:Hypertonic Solutions; D008297:Male; D008353:Mannitol / Q000008:administration & dosage; D008970:Molecular Weight; D013012:Sorbitol / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000008:administration & dosage
D003911:Dextrans; D006982:Hypertonic Solutions; D014665:Vasodilator Agents; D008353:Mannitol; D013012:Sorbitol
Zur Akuttherapie des ischämischen Hirninsults.